DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Art Pappas will participate on a panel called “Venture Capital and Private Equity – How Do You Look for the Next Big Investment” at the Drug Delivery Partnerships conference in Las Vegas, NV
News | 01. 22. 2009
